Approvals/CIMA-AEMPS/MINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

MINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Incyte Biosciences Distribution B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 0ed58befbe372144
Drug Cima Aemps Name: MINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211570001
Holder Company Name: Incyte Biosciences Distribution B.V.
Marketing Company Name: Incyte Biosciences Iberia S.L.
Holder Company Detail Path: /organization/incyte-biosciences-distribution-b-v
Authorization Date: 2021-09-28
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 200 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Incyte Biosciences Distribution B.V.
Company Detail Path: /organization/incyte-biosciences-distribution-b-v

TAFASITAMAB

200 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 28, 2021

Approval ID

0ed58befbe372144

Type

Standard